ClinicalTrials.Veeva

Menu

Fractalkine-CX3CR1 Axis in Periodontal Therapy

G

Giresun University

Status

Completed

Conditions

Periodontitis
Inflammation Biomarkers
Gingivitis

Treatments

Other: Non-surgical periodontal treatment

Study type

Interventional

Funder types

Other

Identifiers

NCT07307144
OMU KAEK 2022/85
SAĞ-BAP-A-240222-47 (Other Grant/Funding Number)

Details and patient eligibility

About

This study aimed to evaluate gingival crevicular fluid (GCF) levels of fractalkine/CX3CL1 and CX3CR1 in patients with gingivitis and periodontitis before and after non-surgical periodontal therapy.

Full description

Thirty stage 3 periodontitis, thirty gingivitis and thirty periodontally healthy individuals were enrolled in the study. Clinical periodontal measurements were recorded; gingivitis and periodontitis patients underwent non-surgical periodontal treatment, and GCF samples were collected at baseline and at 1 and 3 months after treatment. CX3CL1 and CX3CR1 were determined by ELISA.

Enrollment

90 patients

Sex

All

Ages

25 to 47 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. 25-50 years of age
  2. having at least 20 natural teeth, excluding third molars
  3. having no systemic disease
  4. non-smokers
  5. criteria for healthy control group: BOP < 10% and PD ≤ 3 mm without clinical attachment loss or radiographic sign of alveolar bone destruction
  6. criteria for stage 3 periodontitis group: interdental CAL ≥ 5 mm at least 2 non-adjacent teeth, PD ≥ 6 mm and radiographic bone loss extending to the mid-third of the root or beyond.

Exclusion criteria

  1. having any systemic diseases,
  2. smoking
  3. current pregnancy or lactation
  4. a history of periodontal treatment in the past 6 months
  5. using antibiotic, anti-inflammatory drugs or any other drugs within the past 6 months.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

90 participants in 3 patient groups

stage 3 periodontitis
Active Comparator group
Description:
GCF samples were collected at baseline and at 1 and 3 months after treatment from periodontitis patients.
Treatment:
Other: Non-surgical periodontal treatment
Gingivitis
Active Comparator group
Description:
GCF samples were collected at baseline and at 1 and 3 months after treatment from gingivitis patients.
Treatment:
Other: Non-surgical periodontal treatment
Periodontally healthy controls
No Intervention group
Description:
GCF samples were collected from periodontally healthy controls at baseline for once.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems